Cargando…
Integrating Engineering, Manufacturing, and Regulatory Considerations in the Development of Novel Antivenoms
Snakebite envenoming is a neglected tropical disease that requires immediate attention. Conventional plasma-derived snakebite antivenoms have existed for more than 120 years and have been instrumental in saving thousands of lives. However, both a need and an opportunity exist for harnessing biotechn...
Autores principales: | Laustsen, Andreas Hougaard, Dorrestijn, Netty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115708/ https://www.ncbi.nlm.nih.gov/pubmed/30065185 http://dx.doi.org/10.3390/toxins10080309 |
Ejemplares similares
-
Cost of Manufacturing for Recombinant Snakebite Antivenoms
por: Jenkins, Timothy Patrick, et al.
Publicado: (2020) -
Innovative Immunization Strategies for Antivenom Development
por: Bermúdez-Méndez, Erick, et al.
Publicado: (2018) -
Biotechnological Trends in Spider and Scorpion Antivenom Development
por: Laustsen, Andreas Hougaard, et al.
Publicado: (2016) -
Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims †
por: Kini, R. Manjunatha, et al.
Publicado: (2018) -
Antibody Cross-Reactivity in Antivenom Research
por: Ledsgaard, Line, et al.
Publicado: (2018)